Ascendis Pharma Prices 6 Mln IPO At $18 Per ADS

(RTTNews) - Clinical stage biopharmaceutical company Ascendis Pharma A/S (ASND), Wednesday announced the pricing of its initial public offering of 6 million American Depositary Shares at $18.00 per ADS. The trading is expected to begin on the NASDAQ Global Select Market on Wednesday under the ticker symbol ASND.

IPO will be closed on February 2, 2015. The company has granted the underwriters a 30-day option to purchase up to an additional 900,000 ADSs. Ascendis estimates net proceeds of around $96.4 million from the IPO.

BofA Merrill Lynch and Leerink Partners are acting as joint book-running managers for the offering, while Wells Fargo Securities is acting as co-manager.